CD163 and myeloproliferative neoplasm: Multivariate Cox proportional hazards regression modeling determined that both MPN subtype and CD68/CD163 macrophage polarization ratio were independent predictors of thrombosis timing in our cohort, supporting the clinical relevance of incorporating this biomarker into routine risk assessment algorithms.